They described two infants whose clinical and laboratory findings were consistent with SIADH but had undetectable plasma AVP levels because of gain-of-function mutations in the vasopressin V2 receptor (V2R), and coined the term ‘nephrogenic syndrome of inappropriate antidiuresis (NSIAD)’. The gene discussed is AVPR2; the disease is nephrogenic syndrome of inappropriate antidiuresis.